Medherant
Coventry
United Kingdom
Tel: 44-0-024-7632-3060
Fax: 44-0-024-7632-3001
Website: http://www.medherant.co.uk/
Email: info@medherant.co.uk
About Medherant
Medherant was founded by Professor David Haddleton and the University of Warwick to develop and commercialise novel transdermal drug delivery platforms. Current patch technologies have limited drug loading capabilities, making them unviable for use with many pharmaceutical products that could benefit from transdermal delivery. Creams and gels on the other hand suffer from a lack of dose control that is critical for many drugs.YEAR FOUNDED:
2015
LEADERSHIP:
Founder: David Haddleton
CEO: Nigel Davis
CSO: David Haddleton
12 articles about Medherant
-
Cycle Pharmaceuticals and Medherant Partner to Develop Medicines using the TEPI Patch® Technology
5/5/2020
Unique transdermal delivery technology and medicines for rare diseases combine to deliver significant quality-of-life benefits for patients
-
Biotech and pharma companies tap new members of executive leadership teams and boards.
-
Medherant announces positive Phase I results for its first transdermal drug delivery patch
11/5/2018
Medherant has successfully completed two Phase I studies with its novel Ibuprofen TEPI® Patch.
-
Medherant Completes £3.8 Million Funding Round
12/11/2017
This latest investment will support the company as it progresses its ibuprofen TEPI Patch into clinical development in early 2018.
-
Medherant Wins Excellence in Science & Technology Award
11/17/2017
The award recognises Medherant's rapid progress and innovation in the development of next-generation transdermal drug delivery patches.
-
Medherant Signs Agreement With Leading Japanese Transdermal Patch Company For Evaluation Of Its TEPI Patch Drug Delivery System
9/27/2017
-
Medherant Expands Management Team With Appointment Of Sally Waterman, COO And Angus Hone, CFO
6/26/2017
-
Medherant Shortlisted For Royal Society Of Chemistry Emerging Technologies Competition
6/13/2017
-
Medherant Appoints Sheryl Caswell To Lead Clinical Development Of Products Based On Its Revolutionary TEPI Patch
6/6/2017
-
Medherant Appoints Laboratoires Plasto Santé As Transdermal Drug Delivery Patch Manufacturer
5/8/2017
-
Medherant Announces Appointment Of New Chair
2/6/2017
-
Medherant Completes £1.5 Million Fundraising Round For Transdermal Drug Delivery Platform
9/27/2016